Encorafenib plus binimetinib in patients with real-life treated locally advanced, unresectable, or metastatic BRAFV600-mutated melanoma in Spain: a multicenter, retrospective, non-interventional study. BECARE
OTHER OBSERVATIONAL STUDIES WITH MEDICINES
Clinical trial information
- Promoter: SPANISH MULTIDISCIPLINARY MELANOMA GROUP (GEM)
- Execution start: 28/07/2021
- End of execution: 30/06/2022
- IP: SILVIA SEQUERO LOPEZ